THE RELATIONSHIP BETWEEN CCL2 AND CCL5 GEN EXPRESSIONS AND ALLOGRAFT FUNCTION IN PATIENTS UNDERGOING RENAL TRANSPLANTATION

被引:0
|
作者
Verep, Samed [1 ]
Hayriye, Senturk Ciftci [2 ]
Oktar, Tayfun [1 ]
Ziylan, Orhan [1 ]
Kocak, Taner [1 ]
Erdem, Selcuk [1 ]
Turkmen, Aydin [3 ]
Karadeniz, Meltem Savran [4 ]
Sayran, Fatma Oguz [2 ]
Nane, Ismet [1 ]
Tefik, Tzevat [1 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Urol, Istanbul, Turkey
[2] Istanbul Univ, Istanbul Fac Med, Dept Med Biol, Istanbul, Turkey
[3] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Div Nephrol, Istanbul, Turkey
[4] Istanbul Univ, Istanbul Fac Med, Dept Anesthesiol, Istanbul, Turkey
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P5
引用
收藏
页码:310 / 310
页数:1
相关论文
共 50 条
  • [21] Suppression of CCL2/MCP-1 and CCL5/RANTES expression by nociceptin in human monocytes
    Kaminsky, David E.
    Rogers, Thomas J.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2008, 3 (02) : 75 - 82
  • [22] Suppression of CCL2/MCP-1 and CCL5/RANTES Expression by Nociceptin in Human Monocytes
    David E. Kaminsky
    Thomas J. Rogers
    Journal of Neuroimmune Pharmacology, 2008, 3 : 75 - 82
  • [23] CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis - an intravital microscopy study
    dos Santos, AC
    Barsante, MM
    Arantes, RME
    Bernard, CCA
    Teixeira, MM
    Carvalho-Tavares, J
    JOURNAL OF NEUROIMMUNOLOGY, 2005, 162 (1-2) : 122 - 129
  • [24] EXPRESSION OF CHEMOKINES CCL2, CCL5 AND THEIR RECEPTORS CCR2, CCR5 IN INFLAMMATORY BREAST CANCER
    Hamdi, K.
    Hamdi, Kouloud
    Zitoun, R.
    Khadimallah, I.
    Khomsi, F.
    Gamoudi, A.
    Rahal, K.
    Elgaaied, A. Benammar
    Marrakchi, R.
    INFLAMMATION RESEARCH, 2011, 60 : 197 - 197
  • [25] Serum Levels of the CC Chemokines CCL2, CCL5, and CCL11 in Food Allergic Children with Different Clinical Manifestations
    Masood Radman
    Gholamhossin Hassanshahi
    Reza Vazirinejad
    Mohammad Kazemi Arababadi
    Mojgan Noorozi Karimabad
    Hossein Khorramdelazad
    Houshang Rafatpanah
    Fereshteh Iranmanesh
    Elham Hakimizadeh
    Zahra Ahmadi
    Inflammation, 2013, 36 : 561 - 566
  • [26] Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer
    Song, Gina
    Tarrant, Teresa K.
    White, Taylor F.
    Barrow, David A.
    Santos, Charlene M.
    Timoshchenko, Roman G.
    Hanna, Suzan K.
    Ramanathan, Ramesh K.
    Lee, Craig R.
    Bae-Jump, Victoria L.
    Gehrig, Paola A.
    Zamboni, William C.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (07) : 1797 - 1807
  • [27] Innate signaling mechanisms controlling Mycobacterium chelonae-mediated CCL2 and CCL5 expression in macrophages
    Yi Sak Kim
    Ji Hye Kim
    Minjeong Woo
    Tae-sung Kim
    Kyung Mok Sohn
    Young-Ha Lee
    Eun-Kyeong Jo
    Jae-Min Yuk
    Journal of Microbiology, 2015, 53 : 864 - 874
  • [28] Innate signaling mechanisms controlling Mycobacterium chelonae-mediated CCL2 and CCL5 expression in macrophages
    Kim, Yi Sak
    Kim, Ji Hye
    Woo, Minjeong
    Kim, Tae-sung
    Sohn, Kyung Mok
    Lee, Young-Ha
    Jo, Eun-Kyeong
    Yuk, Jae-Min
    JOURNAL OF MICROBIOLOGY, 2015, 53 (12) : 864 - 874
  • [29] Serum Levels of the CC Chemokines CCL2, CCL5, and CCL11 in Food Allergic Children with Different Clinical Manifestations
    Radman, Masood
    Hassanshahi, Gholamhossin
    Vazirinejad, Reza
    Arababadi, Mohammad Kazemi
    Karimabad, Mojgan Noorozi
    Khorramdelazad, Hossein
    Rafatpanah, Houshang
    Iranmanesh, Fereshteh
    Hakimizadeh, Elham
    Ahmadi, Zahra
    INFLAMMATION, 2013, 36 (03) : 561 - 566
  • [30] Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia
    Pang, Yangyang
    Li, Haoran
    Gong, Yuwen
    Jing, Suoshi
    Peng, Cheng
    Liu, Wei
    Zhao, Youli
    Wang, Hanzhang
    Kaushik, Dharam
    Rodriguez, Ronald
    Wang, Zhiping
    ONCOLOGY REPORTS, 2019, 41 (04) : 2491 - 2501